Apollo Medical Holdings Inc
NASDAQ:ASTH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.96
62.54
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Apollo Medical Holdings Inc
Apollo Medical Holdings Inc
Cash & Cash Equivalents
Apollo Medical Holdings Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
Cash & Cash Equivalents
$293.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$764m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$6.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
10%
|
|
Apollo Medical Holdings Inc
Glance View
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,133 full-time employees. The firm through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.
See Also
What is Apollo Medical Holdings Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
293.8m
USD
Based on the financial report for Dec 31, 2023, Apollo Medical Holdings Inc's Cash & Cash Equivalents amounts to 293.8m USD.
What is Apollo Medical Holdings Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
15%
Over the last year, the Cash & Cash Equivalents growth was 2%. The average annual Cash & Cash Equivalents growth rates for Apollo Medical Holdings Inc have been 15% over the past three years .
You don't have any saved screeners yet
